Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Health Care for Women International|August 30, 2008
The patient's perception of having recovered from an eating disorderT Björk, G AhlströmEating and Weight Disorders : EWD|November 1, 2006
Reasons for non-participation in follow-up research on eating disordersT Björk, D Clinton, C NorringBJU International|November 26, 1999
The prognostic value of different forms of prostate specific antigen and their ratios in patients with prostate cancerT Björk, H Lilja, A ChristenssonScandinavian Journal of Infectious Diseases. Supplementum|January 1, 1989
Use of ciprofloxacin in patients undergoing transurethral prostatic surgeryS Hellsten, A Forsgren, T Björk, et al.European Journal of Clinical Microbiology|February 1, 1987
Controlled trial of a short and a prolonged course with ciprofloxacin in patients undergoing transurethral prostatic surgeryM Grabe, A Forsgren, T Björk, et al.Cancer|December 1, 1992
Potential impact on tumor control and organ preservation with cisplatin and 5-fluorouracil for patients with advanced tumors of the paranasal sinuses and nasal fossa. A prospective pilot studyT Björk-Eriksson, C Mercke, B Petruson, et al.Scandinavian Journal of Urology and Nephrology|February 1, 1996
Quantitative bone scintigraphy in patients with prostatic carcinoma treated with LH-RH analoguesG M Sundkvist, T Björk, H Kjellström, et al.International Journal of Radiation Oncology, Biology, Physics|December 30, 1998
Discrimination of human tumor radioresponsiveness using low-dose rate irradiationT Björk-Eriksson, C West, E Karlsson, et al.Nano Letters|September 24, 2005
Tunable double quantum dots in InAs nanowires defined by local gate electrodesCarina Fasth, Andreas Fuhrer, Mikael T Björk, et al.International Journal of Radiation Oncology, Biology, Physics|February 3, 2000
Tumor radiosensitivity (SF2) is a prognostic factor for local control in head and neck cancersT Björk-Eriksson, C West, E Karlsson, et al.Pageof 5